{"summary": "severe acute respiratory syndrome-coronavirus nonstructural protein-10 (SARS-CoV nsp-10) is the main transcriptase of SARS that cleaves polyproteins orf1a (187\u2013260 kDa) and orf1b (345\u2013422 kDa) during infection. the gene is expressed as two different isoforms, isoform A and isoform B, which are 220 and 147 amino acids long. expression of HEPIS was significantly higher in T-47D compared with ZR-75-30, MDA-MB-231 and MCF-7 cells (4). function of HEPIS in breast cancer cell proliferation has not yet been elucidated. psiCHECKTM2 (Promega Corporation) vector was cloned into the psiCHECKTM2 vector using XhoI (CTCGAG) and NotI (GCGGCCGC) restriction sites. the target siRNA sequences for human HEPIS were 5\u2032-GATGCTAACCTCCAAGTTT-3\u2032, 5\u2032-GCAAGCAGCAGAAGAGAAA-3\u2032 and 5\u2032-AGTTTAGTCCTGCAGAT-3 pEGFP-C3-HEPISa, pEGFP-C3-HEPISb, or pEGFP-C3-HEPISb were seeded at a density of 7104 cells/well in 24-well plates. after 24 h of culture, the cells were transfected with 800 ng/well pEGFP-C3, pEGFP-C3-HEPISa or pEGFP-C3-HEPISb plasm the cells were transfected with 800 ng/well of either pEGFP-C3-HEPISa, pEGFP-C3-HEPISb or pEGFP-C3 for western blotting. at 24 h post-transfection, western blotting was performed as described previously. psiCHECKTM-2 vector MCF-7 cells were transfected with the psiCHECKTM-2 vector. at 24 h, the cells were lysed and cell lysates were assayed for firefly. the cells were seeded into 96-well plates at a density of 2103 cells/well. pNF-B-Luc was cloned into the 3\u2032UTR of firefly luciferase. the internal control plasmid contained the Renilla luciferase gene. at 24 h post-transfection, the DLR assay was performed using the manufacturer's protocol. labeled complementary RNA (cRNA) was purified using the RNeasy mini kit (cat. no. 74106; Qiagen GmbH) as previously described (16). each slide (Agilent SurePrint G3 Human Gene Expression Microarray 860K) was hybridized with 600 ng Cy3-labeled cRNA. RNA was extracted using TRIzol\u00ae (Invitrogen; Thermo Fisher Scientific, Inc.) and purified using RNeasy mini kit (Qiagen GmbH) total RNA (0.5 g) from each sample was used for first-strand cDNA synthesis using M-MLV reverse transcription kit (Promega Corporation) pEGFP-C3-HEPISa plasmid contained the CDS sequence of HEPIS isoform A. pEGFP-C3-HEPISa plasmid contained the CDS sequence of HEPIS isoform A. pEGFP-C3-HEPISb plasmid contained the CDS sequence of HEPIS isoform B. psiCHECKTM2 (Promega Corporation) vector was cloned into the psiCHECKTM2 vector using XhoI (CTCGAG) and NotI (GCGGCCGC) restriction sites. oligonucleotides were annealed and ligated into pSilencer 4.1-CMVneo (Ambion; Thermo Fisher Scientific, Inc.) to construct HEPIS-specific siRNA expression the cells were seeded at a density of 1104 cells/well in 96-well plates. after 24 h of culture, the cells were transfected with 800 ng/well pEGFP-C3-HEPISa, pEGFP-C3-HEPISb or pEGFP-C3-HEPISb. cells were seeded at a density of 7104 cells/well in 24-well plates. cells were transfected with 800 ng/well of either pEGFP-C3-HEPISa, pEGFP-C3-HEPISb or pEGFP-C3 for western blotting. the psiCHECKTM-2 vector MCF-7 cells were transfected with the psiCHECKTM-2 vector as aforementioned. at 24 h, the cells were lysed and cell lysates were assayed for firefly and Renilla luciferase activity using a dual-Luciferase reporter assay system. pNF-B-Luc was cloned into the 3\u2032UTR of firefly luciferase. the internal control pRL-TK plasmid contained the Renilla luciferase gene. labeled complementary RNA (cRNA) was purified using the RNeasy mini kit (cat. no. 74106; Qiagen GmbH) as previously described (16). each slide (Agilent SurePrint G3 Human Gene Expression Microarray 860K) was hybridized with 600 ng Cy3-labeled cRNA. analysis of differentially expressed mRNAs performed as described previously. RNA extracted using TRIzol\u00ae (Invitrogen; Thermo Fisher Scientific, Inc.) qPCR was performed using 94\u00b0C for 15 sec, 60\u00b0C for 15 sec and 72\u00b0C for 15 sec for 40 cycles. the data of RT-qPCR and EdU cell proliferation assay were analyzed using Student's t-test. P0.05 was considered to indicate a statistically significant difference. pEGFP-C3-HEPISb plasmid contained the CDS sequence of HEPIS isoform A. the PCR fragments were cloned into the psiCHECKTM2 vector using XhoI (CTCGAG) and notI (GCGGCCGC) restriction sites. the target siRNA sequences for human HEPIS were 5\u2032-GATGCTAACCTCCAAGTTT-3\u2032, 5\u2032-GCAAGCAGCA cells were seeded at a density of 1104 cells/well in 96-well plates. after 24 h of culture, the cells were transfected with 800 ng/well pEGFP-C3-HEPISa, pEGFP-C3-HEPISb, or pEGFP-C3-HEPISb plasmids. pEGFP-C3-HEPISb, pEGFP-C3-HEPISb, pEGFP-C3-HEPISb, si-control or pRL-TK were seeded at a density of 7104 cells/well in 24-well plates. after 24 h of culture, the cells were transfected with 800 ng/well of either pEGFP-C3-HEPISa, pEGFP-C3-HEPIS at 24 h, the cells were lysed and cell lysates were assayed for firefly and Renilla luciferase activity. at 24 h, the cells were seeded into 96-well plates at a density of 2103 cells/well. pNF-B-Luc reporter plasmid contains the NF-B response element. pNF-B-Luc was used to measure transcriptional activity of NF-B. the internal control pRL-TK plasmid contained the Renilla luciferase gene. RNA was purified using TRIzol (cat. no. 15596-018; Invitrogen; Thermo Fisher Scientific, Inc.) RNA was amplified and labeled using the low input quick amp labeling kit, one-color (cat. no. 5190-2305; Agilent Technologies, Inc.) GO enrichment (http://geneontology.org, release number 2019-01-01) and KEGG pathway (http://www.genome.jp/kegg, release number 91.0, July 2019) analysis of the differentially expressed mRNAs were performed as described previously (18. RNA extraction, purification and reverse transcription were performed as described previously. GGAGACAGAGGAA-3\u2032 and reverse, 5\u2032-CCTGGGCGACCATTTAGC-3\u2032; IFNAR2 forward, 5\u2032-TGATAGCGATACTGAGGC-3\u2032; and reverse, 5\u2032-CTGATTCTGTAGAGGTG-3\u2032; and IFNA8 forward, 5\u2032-GACTCATCTGCTGTGTGTTA-3\u2032. GAPDH was used as an internal control. RT-qPCR and EdU cell proliferation assay were protein analyses on TMHMM revealed that the HEPIS protein has no predicted transmembrane domain. cDNAs of both the isoforms were fused to GFP in the pEGFP-C3 vector and transfected into HeLa cells. overexpression of HEPISa and HEPISb was confirmed using qPCR. pEGFP-C3-HEPISa, or pEGFP-C3-HEPISb, and nuclei were stained with DAPI was used to stain nuclei. Western blot analysis with anti-GFP antibodies was performed to determine expression of HEPIS-GFP in MCF-7 cells. Specimen Number Optical density Integrated optical density Normal breast tissue 39 0.0380.001a 18713.51a Breast cancer 39 0.0200.001 10910.72 a P0.05, Student's t-test. the knockdown of HEPIS by siHEPIS-3 significantly increased the number of MCF-7 cells compared with the control. overexpression of both isoforms of HEPIS decreased the number of cells in the S phase from 51.2 to 38.1% (HEPISa) or 36.3% (HEPISb) MCF-7 cells were transfected with either (A) pEGFP-C3, pEGFP-C3-HEPISa or pEGFP-C3-HEPISb. cell proliferation was measured by immunofluorescence analysis of EdU incorporation. gene chip analysis was performed to identify mRNAs differentially expressed. 2,231 genes were differentially expressed in HEPIS-overexpressing cells. 1,095 genes that were upregulated and 1,136 that were downregulated. MCF-7 cells were transfected with either pEGFP-C3 or pEGFP-C3-HEPISa. the IL2RA, IFNAR2 and IFNA8 mRNA levels were detected. 0043552 Positive regulation of phosphatidylinositol 3-kinase activity BP 0.0002 7 TGFB1, CCL19, FGF2, PDGFB, FGFR3, FLT1, CCL21 5.69 GO:0010560 Positive regulation of glycoprotein biosynthetic process BP 0.0031 4 CCL19, PXYLP1, CCL21, SLC51B 5.69 GO:0043551 Regulation of phosphatid us' 0.0234 5 HLA-DQB1, CD86, HLA-DQA1, HLA-B, TNF 2.73 hsa00770 \u2018Pantothenate and CoA biosynthesis\u2019 0.0867 2 DPYS, PPCDC 2.61 hsa04660 \u2018T cell receptor signaling pathway\u2019 0.0052 11 PAK7, PIK3R5, CBLC, PTPRC, MAPK3, etc. 2.45 hsa04630 cDNAs of both isoforms were fused to GFP in the pEGFP-C3 vector. pEGFP-C3-HEPISa expressed a 55-kDa HEPISa-GFP fusion protein. pEGFP-C3-HEPISb plasmids expressed a 45-kDa HEPISb-GFP fusion protein in MCF-7 cells. the HEPIS mRNA levels were detected using quantitative PCR 24 h after transfection. pEGFP-C3, pEGFP-C3-HEPISa, or pEGFP-C3-HEPISb. HEPIS, human embryo lung cellular protein interacting with severe acute respiratory syndrome-coronavirus nonstructural protein-10. HEPIS overexpression reduces proliferation of MCF-7 cells. the results revealed that HEPIS expression was lowest in cells transfected with siHEPIS-3. qPCR analysis showed that overexpression of siHEPIS-3 significantly reduced expression of HEPIS at the transcriptional level. the knockdown of HEPIS by siHEPIS-3 significantly reduced the expression of HEPIS at the transcriptional level. MCF-7 cells were transfected with either si-control or siHEPIS-3. the HEPIS mRNA levels were detected using quantitative PCR. mCF-7 cells were transfected with either (A) pEGFP-C3, pEGFP-C3-HEPISa, or pEGFP-C3-HEPISb and (B) si-control or siHEPIS-3, along with pNF-B-luc (80 ng) the dual-luciferase reporter assay was performed using lysates from transfected cells. qPCR results confirmed that the mRNA levels of these three genes were downregulated in HEPIS-overexpressing MCF-7 cells compared with that in the pEGFP-C3 group at 24 and 48 h post-transfection. pEGFP-C3-expressing MCF-7 cells were transfected with either pEGFP-C3-HEPISa. BP 0.0018 4 HLA-B, CD86, CBLB, IL2RA 6.5 GO:0004675 Transmembrane receptor protein serine/threonine kinase activity MF 0.0031 4 ACVR1, ACVR1B, AMHR2, TGFBR3 5.69 GO:0010888 Negative regulation of lipid storage BP 0.0031 4 TNF, PPARA, NR1H2, ABCA1 5.69 GO:00 3.31 hsa05330 \u2018Allograft rejection\u2019 0.0133 5 HLA-DQB1, CD86, HLA-DQA1, HLA-B, TNF 2.86 hsa04940 \u2018Type I diabetes mellitus\u2019 0.0234 5 HLA-DQB1, CD86, HLA-DQA1, HLA-B, TNF 2.73 hsa00770 \u2018Pantothenate and CoA biosynthesis\u2019 0.0867 2 1.73 hsa04010 \u2018MAPK signaling pathway\u2019 0.0364 18 NGF, FGF3, NR4A1, FGFR2, FGFR3, etc. 1.31 MAPK, mitogen-activated protein kinase. PCR was performed to determine expression levels of the A and B isoforms in MCF-7 cells. pEGFP-C3, pEGFP-C3-HEPISa, or pEGFP-C3-HEPISb, were transfected with pEGFP-C3-HEPISb. the mRNA levels were detected using quantitative PCR 24 h after transfection. RNA in situ hybridization was performed using a tissue microarray containing breast cancer tissue and adjacent normal tissue from 39 cases. HEPIS-positive staining was primarily found in the cytoplasm of case 2. the results of the CCK-8 assay indicated that overexpression of both isoforms of HEPIS in MCF-7 cells significantly decreased the cell proliferation compared with MCF-7 cells transfected with empty vector controls. the results revealed that HEPIS expression was lowest in cells transfected with siHEPIS-3. MCF-7 cells were transfected with pEGFP-C3, pEGFP-C3-HEPISa or pEGFP-C3-HEPISb. the dual-luciferase reporter assay was performed. the Renilla luciferase data are normalized to the expression of firefly luciferase. the two isoforms of HEPIS overexpression significantly inhibited the NF-kB reporter gene in MCF-7 cells compared with the control group. by contrast, HEPIS knockdown resulted in a significant increase in NF-b reporter gene activity in MCF-7 cells. top 15 significant enrichment pathways from KEGG pathways are listed in Table III.'mitogen-activated protein kinase (MAPK) signaling pathway', 'Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway', 'focal adhesion' and others. mRNA levels of these three genes were downregulated in HEPIS-overexpressing MCF-7 cells compared with that in X7, PLSCR2, ANO3 7 GO:0002664 Regulation of T cell tolerance induction BP 0.0014 4 HLA-B, CD86, CBLB, IL2RA 7 GO:0042659 Regulation of cell fate specification BP 0.0018 4 FGF2, POU5F1, GFI1, DKK1 6.5 GO:0070307 Lens fiber cell development BP 0.0018 4 FGFR3, FGFR2, WNT7A, W pathway ID Description P-value Gene count Genes Enrichment factor hsa00780 \u2018Biotin metabolism\u2019 0.0152 1 BTD 7.83 hsa04320 \u2018Dorso-ventral axis formation\u2019 0.0031 5 PIWIL3, MAPK3, ETV7, ETS1, NOTCH1) 4.19 hsa04976 \u2018Bile secretion\u2019 0.0007 10 ABCC2, SLCO1A2, ABCG5, SLC9A 2.4 hsa04672 \u2018Intestinal immune network for IgA production\u2019 0.4137 5 HLA-DQB1, CXCL12, TGFB1, CD86, HLA-DQA1 1.93 hsa04010 \u2018MAPK signaling pathway\u2019 0.0359 15 PXN, PAK7, FLT1, ZYX, ACTN2, COMP, etc. 1.73 hsa04310 \u2018MAPK signaling pathway\u2019 0.3337 8 W the difference in expression of the HEPIS gene does not completely determine the growth rate of MCF-7 and T-47D cells. the difference in expression of the HEPIS gene does not completely determine the growth rate of MCF-7 and T-47D cells. serine/threonine protein kinases are involved in different cellular processes, such as proliferation, survival, apoptosis, differentiation, motility and development. ERK, JNK/stress-activated protein kinase, and p38 are three major MAPK families that serve important roles in tumor progression in breast cancer. authors' contributions FH, YZ, and ML performed the in vitro experiments. XZ performed the RNA in situ hybridization."}